Cargando…
Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol
INTRODUCTION: Cachexia is common in malignant mesothelioma (MM); half of patients have malnutrition and low skeletal muscle mass. Malnourished patients have worse quality of life (QoL). Weight loss is strongly associated with poor survival. Anamorelin is an oral ghrelin receptor agonist that improve...
Autores principales: | Hoon, Siao Nge, Fyfe, Katrina, Peddle-McIntyre, Carolyn J, Bowyer, Samantha, Hawkins, Felicity, Jeffery, Emily, Chih, Hui Jun, Creaney, Jenette, Nowak, Anna, Brims, Fraser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173983/ https://www.ncbi.nlm.nih.gov/pubmed/32213537 http://dx.doi.org/10.1136/bmjresp-2019-000551 |
Ejemplares similares
-
Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015) -
Living beyond expectations: a qualitative study into the experience of long-term survivors with pleural mesothelioma and their carers
por: Johnson, Matthew, et al.
Publicado: (2022) -
Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire
por: Senek, Michaela, et al.
Publicado: (2022) -
Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors
por: Kidd, Andrew C, et al.
Publicado: (2018) -
Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria
por: Kidd, Andrew C, et al.
Publicado: (2022)